Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations

被引:0
|
作者
Rudakou, Uladzislau [1 ,2 ]
Yu, Eric [1 ,2 ]
Krohn, Lynne [1 ,2 ]
Ruskey, Jennifer A. [2 ,3 ]
Asayesh, Farnaz [2 ,3 ]
Dauvilliers, Yves [4 ]
Spiegelman, Dan [2 ,3 ]
Greenbaum, Lior [5 ,6 ,7 ]
Fahn, Stanley [8 ]
Waters, Cheryl H. [8 ]
Dupre, Nicolas [9 ,10 ]
Rouleau, Guy A. [1 ,2 ,3 ]
Hassin-Baer, Sharon [7 ,11 ,12 ]
Fon, Edward A. [2 ,3 ]
Alcalay, Roy N. [8 ,13 ]
Gan-Or, Ziv [1 ,2 ,3 ]
机构
[1] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Montreal Neurol Inst, 1033 Pine Ave,Ludmer Pavil,Room 312, Montreal, PQ H3A 1A1, Canada
[3] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 1A1, Canada
[4] Univ Montpellier, Gui de Chauliac Hosp, Natl Reference Ctr Narcolepsy, Dept Neurol,Inserm U1061,Sleep Unit,CHU Montpelli, Montpellier, France
[5] Sheba Med Ctr, Danek Gertner Inst Human Genet, Ramat Gan, Israel
[6] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel
[7] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[8] Columbia Univ, Coll Phys & Surg, Dept Neurol, Med Ctr, New York, NY 10032 USA
[9] Univ Laval, Div Neurosci, CHU Quebec, Quebec City, PQ G1V 0A6, Canada
[10] Univ Laval, Fac Med, Dept Med, Quebec City, PQ G1V 0A6, Canada
[11] Sheba Med Ctr, Dept Neurol, Ramat Gan, Israel
[12] Sheba Med Ctr, Movement Disorders Inst, Ramat Gan, Israel
[13] Columbia Univ Med Ctr, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
Parkinson's disease; genetic fine mapping; risk loci; association study; sequencing;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Genome-wide association studies (GWAS) have identified numerous loci associated with Parkinson's disease. The specific genes and variants that drive the associations within the vast majority of these loci are unknown. We aimed to perform a comprehensive analysis of selected genes to determine the potential role of rare and common genetic variants within these loci. We fully sequenced 32 genes from 25 loci previously associated with Parkinson's disease in 2657 patients and 3647 controls from three cohorts. Capture was done using molecular inversion probes targeting the exons, exon-intron boundaries and untranslated regions (UTRs) of the genes of interest, followed by sequencing. Quality control was performed to include only high-quality variants. We examined the role of rare variants (minor allele frequency < 0.01) using optimized sequence Kernel association tests. The association of common variants was estimated using regression models adjusted for age, sex and ethnicity as required in each cohort, followed by a meta-analysis. After Bonferroni correction, we identified a burden of rare variants in SYT11, FGF20 and GCH1 associated with Parkinson's disease. Nominal associations were identified in 21 additional genes. Previous reports suggested that the SYT11 GWAS association is driven by variants in the nearby GBA gene. However, the association of SYT11 was mainly driven by a rare 3 UTR variant (rs945006601) and was independent of GBA variants (P=5.23x10(-5) after exclusion of all GBA variant carriers). The association of FGF20 was driven by a rare 5' UTR variant (rs1034608171) located in the promoter region. The previously reported association of GCH1 with Parkinson's disease is driven by rare non-synonymous variants, some of which are known to cause dopamine-responsive dystonia. We also identified two LRRK2 variants, p.Arg793Met and p.Gln1353Lys, in 10 and eight controls, respectively, but not in patients. We identified common variants associated with Parkinson's disease in MAPT, TMEM175, BST1, SNCA and GPNMB, which are all in strong linkage disequilibrium with known GWAS hits in their respective loci. A common coding PM20D1 variant, p.Ile149Val, was nominally associated with reduced risk of Parkinson's disease (odds ratio 0.73, 95% confidence interval 0.60-0.89, P=1.161x10(-3)). This variant is not in linkage disequilibrium with the top GWAS hits within this locus and may represent a novel association. These results further demonstrate the importance of fine mapping of GWAS loci, and suggest that SYT11, FGF20, and potentially PM20D1, BST1 and GPNMB should be considered for future studies as possible Parkinson's disease-related genes.
引用
收藏
页码:462 / 472
页数:11
相关论文
共 25 条
  • [1] Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations
    Rudakou, Uladzislau
    Yu, Eric
    Krohn, Lynne
    Ruskey, Jennifer A.
    Asayesh, Farnaz
    Dauvilliers, Yves
    Spiegelman, Dan
    Greenbaum, Lior
    Fahn, Stanley
    Waters, Cheryl H.
    Dupre, Nicolas
    Rouleau, Guy A.
    Hassin-Baer, Sharon
    Fon, Edward A.
    Alcalay, Roy N.
    Gan-Or, Ziv
    BRAIN, 2021, 144 (02) : 462 - 472
  • [2] Association analysis of SYT11, FGF20, GCH1 rare variants in Parkinson's disease
    Pu, Jia-li
    Lin, Zhi-Hao
    Zheng, Ran
    Yan, Yi-Qun
    Xue, Nai-jia
    Yin, Xin-zhen
    Zhang, Bao-Rong
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (01) : 175 - 177
  • [3] Roles of FGF20 in doparninergic neurons and Parkinson's disease
    Itoh, Nobuyuki
    Ohta, Hiroya
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2013, 6
  • [4] Genetic analysis of FGF20 in Chinese patients with Parkinson's disease
    Sun, Xiao-Yi
    Wang, Ling
    Cheng, Lan
    Li, Nan-Nan
    Lu, Zhong-Jiao
    Li, Jun-Ying
    Peng, Rong
    NEUROLOGICAL SCIENCES, 2017, 38 (05) : 887 - 891
  • [5] Genetic analysis of FGF20 in Chinese patients with Parkinson’s disease
    Xiao-Yi Sun
    Ling Wang
    Lan Cheng
    Nan-Nan Li
    Zhong-Jiao Lu
    Jun-Ying Li
    Rong Peng
    Neurological Sciences, 2017, 38 : 887 - 891
  • [6] The Parkinson’s disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway
    Carla F. Bento
    Avraham Ashkenazi
    Maria Jimenez-Sanchez
    David C. Rubinsztein
    Nature Communications, 7
  • [7] The Parkinson's disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway
    Bento, Carla F.
    Ashkenazi, Avraham
    Jimenez-Sanchez, Maria
    Rubinsztein, David C.
    NATURE COMMUNICATIONS, 2016, 7
  • [8] FGF20 and Parkinson's Disease: No Evidence of Association or Pathogenicity via α-Synuclein Expression
    Wider, Christian
    Dachsel, Justus C.
    Soto, Alexandra I.
    Heckman, Michael G.
    Diehl, Nancy N.
    Yue, Mei
    Lincoln, Sarah
    Aasly, Jan O.
    Haugarvoll, Kristoffer
    Trojanowski, John Q.
    Papapetropoulos, Spiridon
    Mash, Deborah
    Rajput, Alex
    Rajput, Ali H.
    Gibson, J. Mark
    Lynch, Timothy
    Dickson, Dennis W.
    Uitti, Ryan J.
    Wszolek, Zbigniew K.
    Farrer, Matthew J.
    Ross, Owen A.
    MOVEMENT DISORDERS, 2009, 24 (03) : 455 - 459
  • [9] Screening of polymorphisms located in the FGF20 and TMEM175 genes in North Chinese Parkinson's disease patients
    Jing, C. C.
    Luo, X. G.
    Cui, H. G.
    Li, F. R.
    Li, P.
    Jiang, E. Z.
    Ren, Y.
    Pang, H.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 13679 - 13687
  • [10] Fibroblast growth factor 20 (FGF20) polymorphism is a risk factor for Parkinson's disease in Chinese population
    Pan, Jing
    Li, Hui
    Wang, Ying
    Ma, Jian-Fang
    Zhang, Jin
    Wang, Gang
    Liu, Jun
    Wang, Xi-Jin
    Xiao, Qin
    Chen, Sheng-Di
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (05) : 629 - 631